What is the recommended protocol for neonatal pulse‑oximetry screening, including timing, sensor placement, interpretation criteria, and management of abnormal results in term and preterm infants?

Neonatal Pulse Oximetry Screening Protocol

Screen all asymptomatic term and late preterm newborns at ≥24 hours of life (or before discharge if earlier) using the simplified algorithm with oxygen saturation ≥95% in BOTH pre-ductal (right hand) and post-ductal (foot) measurements, allowing only ONE retest if initial screening is indeterminate. 1

Timing of Screening

Perform screening after 24 hours of life when feasible to minimize false-positive results. The false-positive rate drops significantly when screening occurs >24 hours after birth (0.06%) compared to <24 hours (0.42%) 2. However, screening must occur before discharge from the well-baby nursery, so if discharge is planned earlier, screen between 1-4 hours of life at minimum 3.

Sensor Placement

Measure oxygen saturation at two sites:

• Pre-ductal: Right hand (upper extremity)
• Post-ductal: Either foot (lower extremity)

This dual-site approach detects both generalized hypoxemia and differential cyanosis from ductal-dependent lesions 1.

Clinical Conditions Required

The infant must be:

• In room air (FiO2 = 21%) with no supplemental oxygen
• Asymptomatic and clinically well-appearing
• Off any respiratory support, or if on support, receiving only room air 1

Critical pitfall: Never screen infants receiving supplemental oxygen, as this creates false-negative results and defeats the purpose of screening 1.

Interpretation Criteria (Simplified Algorithm)

PASS Criteria:

• SpO₂ ≥95% in BOTH right hand AND foot measurements
• AND difference between sites <3%

FAIL Criteria (requires immediate evaluation):

• SpO₂ <90% in either site
• OR SpO₂ 90-94% in both sites after ONE retest (performed 1 hour later)
• OR SpO₂ difference ≥3% between sites persisting after ONE retest

Key change from older protocols: The 2025 AAP guideline endorses only ONE retest instead of two, which shortens time to CCHD recognition without meaningfully increasing false-positives 1. The threshold is now uniformly ≥95% for both sites, eliminating previous confusion about different cutoffs 1.

Management of Abnormal Results

Immediate Actions for Failed Screening:

1. Perform echocardiography as the definitive diagnostic test 1

2. Evaluate for non-cardiac causes of hypoxemia:

   • Respiratory pathology (pneumonia, persistent pulmonary hypertension, respiratory distress syndrome)
   • Sepsis or infection
   • Metabolic disorders

   Approximately 32-39% of failed screens identify clinically significant non-cardiac conditions 4.

3. Do NOT discharge until evaluation is complete and diagnosis established

4. Consult pediatric cardiology for interpretation of echocardiogram and management planning

Expected Performance Characteristics:

The screening will detect approximately 76% of CCHD cases (sensitivity) with 99.9% specificity 2. This means:

• Out of 10,000 screened infants with 6 having CCHD (typical prevalence):
  • 5 cases will be detected
  • 1 case will be missed
  • 14 false-positives will occur 2

Critical caveat: A passed screen does NOT rule out CCHD. Sensitivity is only 50-76%, so maintain clinical vigilance for signs of cardiac disease even after normal screening 1. Some CCHDs (particularly those with left-to-right shunts or obstructed pulmonary venous return) may not cause hypoxemia initially.

Special Populations

Cesarean Section Deliveries:

Infants born by C-section show higher rates of low SpO₂ at early timepoints due to delayed fluid clearance 5. This reinforces the importance of screening after 24 hours when possible.

Out-of-Hospital Births:

For home births or birth center deliveries, perform early screen at 1-4 hours AND late screen at 24-48 hours. Combined screening maintains sensitivity while accommodating typical midwifery care patterns 3.

Preterm Infants:

The protocol applies to late preterm infants (≥35 weeks gestation). Earlier preterm infants in the NICU require different oxygen saturation management strategies and are not candidates for routine CCHD screening 6.

Data Collection Requirements

Document the following minimum dataset 1:

• Age in hours at screening
• Pre-ductal and post-ductal SpO₂ values for each screen
• Pass/fail outcome
• For failures: CCHD type identified (if any) and non-CCHD conditions identified

This standardized data collection enables quality improvement and detection of false-negative cases through linkage with birth defects registries 1.